Results 291 to 300 of about 28,480 (301)

Breast cancer statistics, 2017, racial disparity in mortality by state

Ca-A Cancer Journal for Clinicians, 2017
Carol E Desantis, Ann Goding Sauer, Lisa Newman   +2 more
exaly  

Breast cancer statistics, 2019

Ca-A Cancer Journal for Clinicians, 2019
Carol E Desantis, Jiemin Ma, Mia M Gaudet   +2 more
exaly  

The crucial roles of IFN-γ in the development of M3 muscarinic acetylcholine receptor induced Sjögren’s syndrome-like sialadenitis

Modern Rheumatology, 2013
M. Iizuka, H. Tsuboi, N. Matsuo, Y. Kondo, H. Asashima, M. Matsui, I. Matsumoto, T. Sumida   +7 more
semanticscholar   +1 more source

Gastroenteropancreatic Neuroendocrine Tumors

Ca-A Cancer Journal for Clinicians, 2018
Mauro Cives, Jonathan Strosberg
exaly  

Lung cancer: New biological insights and recent therapeutic advances

Ca-A Cancer Journal for Clinicians, 2011
Suresh S Ramalingam, Taofeek K Owonikoko, Fadlo R Khuri   +2 more
exaly  

High expression of M3 muscarinic acetylcholine receptor is a novel biomarker of poor prognostic in patients with non-small cell lung cancer

Tumor Biology, 2013
Jun Wu, Jinxu Zhou, L. Yao, Yaoguo Lang, Yingnan Liang, Lantao Chen, Jin-feng Zhang, Feng-Jun Wang, Yanbo Wang, He Chen, Jianqun Ma   +10 more
semanticscholar   +1 more source

Advances in Prostate Cancer Chemotherapy: A New Era Begins

Ca-A Cancer Journal for Clinicians, 2005
Kenneth J Pienta, David C Smith
exaly  

Generation and functional analysis of monoclonal antibodies against the second extracellular loop of human M3 muscarinic acetylcholine receptor

Modern Rheumatology, 2012
H. Tsuboi, Yumi Nakamura, M. Iizuka, N. Matsuo, I. Matsumoto, T. Sumida   +5 more
semanticscholar   +1 more source

Novel Agents on the Horizon for Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2009
exaly  

Targeting Apoptosis Pathways in Cancer Therapy

Ca-A Cancer Journal for Clinicians, 2005
exaly